Kiley Juergens Wealth Management LLC Purchases Shares of 3,300 Marsh & McLennan Companies, Inc. $MRSH

Kiley Juergens Wealth Management LLC purchased a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 3,300 shares of the financial services provider’s stock, valued at approximately $572,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC increased its stake in shares of Marsh & McLennan Companies by 51.2% during the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock valued at $1,856,000 after buying an additional 2,960 shares during the period. Bison Wealth LLC lifted its stake in Marsh & McLennan Companies by 39.6% in the fourth quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after acquiring an additional 869 shares during the period. Glenview Trust co boosted its holdings in Marsh & McLennan Companies by 10.8% in the second quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after acquiring an additional 379 shares in the last quarter. Osterweis Capital Management Inc. increased its position in Marsh & McLennan Companies by 18,440.0% during the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock valued at $203,000 after purchasing an additional 922 shares during the period. Finally, Diversify Advisory Services LLC bought a new position in Marsh & McLennan Companies in the 2nd quarter worth $1,307,000. 87.99% of the stock is owned by institutional investors.

Insider Buying and Selling at Marsh & McLennan Companies

In related news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the transaction, the chief executive officer owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This trade represents a 12.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by insiders.

Marsh & McLennan Companies Trading Up 1.9%

Shares of Marsh & McLennan Companies stock opened at $177.99 on Wednesday. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $216.32. The stock has a market capitalization of $85.99 billion, a P/E ratio of 22.25, a price-to-earnings-growth ratio of 2.54 and a beta of 0.61. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion during the quarter. The firm’s revenue for the quarter was up 7.6% compared to the same quarter last year. Equities research analysts forecast that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Analysts Set New Price Targets

MRSH has been the topic of a number of research reports. JPMorgan Chase & Co. cut their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating on the stock in a research note on Thursday, April 9th. Keefe, Bruyette & Woods raised their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the stock a “market perform” rating in a report on Friday, April 17th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price objective on the stock in a research report on Wednesday, May 6th. Piper Sandler reduced their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. Finally, Morgan Stanley lowered their target price on Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating for the company in a research note on Monday. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Marsh & McLennan Companies currently has an average rating of “Hold” and a consensus target price of $199.25.

Marsh & McLennan Companies Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.